Albemarle’s Q4 2025 Earnings: What to Expect

Core Insights - Albemarle Corporation is a global leader in specialty chemicals, focusing on lithium and bromine, with a market capitalization of $20.82 billion [1] Financial Performance - The company is expected to report a loss of $0.62 per share for Q4 fiscal 2025, reflecting a 43.1% year-over-year improvement [2][3] - For the full fiscal year 2025, analysts anticipate a 53% reduction in diluted loss per share to $1.10, followed by a significant 249.1% improvement to an EPS of $1.64 in fiscal 2026 [3] Stock Performance - Albemarle's stock has surged 91.7% over the past 52 weeks and 147% over the past six months, significantly outperforming the S&P 500 Index, which increased by 18.6% and 10.5% during the same periods [4] - Compared to its sector, represented by the State Street Materials Select Sector SPDR ETF, which rose by 13.1% over the past 52 weeks and 7.1% over the past six months, Albemarle has also outperformed [5] Recent Developments - In its third-quarter results for fiscal 2025, Albemarle reported net sales of $1.31 billion, a 3.5% decline year-over-year, primarily due to lower pricing in the Energy Storage segment, but offset by 8% volume growth in both the Energy Storage and Ketjen segments [6] - The adjusted loss per share for the third quarter decreased by 87.7% from the prior-year period to $0.19, and the stock gained 6.5% intraday following the earnings report [6]